Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III TrialsCesare Gridelli, Francesco Perrone, Alessandro Morabito et al.|Journal of Clinical Oncology|2018Cited by 70
Polymorphisms of glutathione‐<i>S</i>‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesotheliomaStefano Landi, Riccardo Puntoni, Manlio Mencoboni et al.|International Journal of Cancer|2007Cited by 55
Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future DevelopmentMarina Elena Cazzaniga, Guido Bocci, Andrea Camerini et al.|Future Oncology|2015Cited by 54
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolismFederica Gemignani, Stefano Landi, Monica Neri et al.|Mutation research. Fundamental and molecular mechanisms of mutagenesis|2009Cited by 18
Biosimilar epoetin alfa in the management of chemotherapy-induced aneamia: results from ANEMONE observational studyE. Scelzi, Giovanni Rosti, Daniela Bernardi et al.|Annals of Oncology|2015Cited by 1